TABLE 1.

Demographic and clinical characteristics of PLWH, by HBsAg testing status

Characteristics		HBsAg screening status				P
		Never tested n = 689		Previously tested n = 387
Sex (n[%])	Male	227	[33.0]	158	[40.8]	0.02
	Female	460	[68.0]	229	[59.2]
	Unknown	2	[0.3]	0	[0]
Age, years	Median (IQR)	47	[39–55]	45	[34–53]	<0.001
Employment status (n[%])	Employed	468	[84.8]	299	[77.3]	<0.001
	Student	33	[6.0]	46	[11.9]
	Unemployed	50	[7.3]	15	[3.9]
	Unknown	138	[20.0]	27	[7.0]
WHO stage at presentation (n[%])	I–II	228	[33.1]	152	[39.3]	<0.001
	III–IV	345	[50.1]	215	[55.6]
	Unknown	116	[16.8]	20	[5.1]
Period of ART initiation, years (n[%])	1998–2013	411	[59.7]	132	[34.1]	<0.001
	2014–2019	229	[33.2]	254	[65.6]
	Unknown	49	[7.1]	1	[0.3]
CD4 at ART initiation, cel/ul (n[%])	<200	287	[41.7]	187	[48.3]	<0.001
	200+	165	[24.0]	129	[33.3]
	Unknown	237	[34.4]	71	[18.5]
Time on ART, years	Median (IQR)	9,3	[4.8–12.8]	4,8	[2.5–8.5]	<0.001
ART line regimen (n[%])	1st line	507	[73.6]	334	[86.3]	<0.001
	2nd/3rd line	117	[17.0]	47	[12.1]
	Unknown	65	[9.4]	6	[1.6]

Abbreviations: ART, Antiretroviral treatment; HBsAg, Hepatitis B virus surface antigen; IQR, interquartile range; WHO, world health organization.